WSI Co. Ltd.

299170 · KQ · Financial Services / Shell Companies

1,113.00KRW+7.00 (+0.63%)

Price History

Full chart

Market Stats

Previous Close1,106.00

Open1,114.00

Day Range1,103.00 – 1,146.00

52-Week Range1,012.00 – 5,000.00

Volume83.38K

Market Cap61.19B

P/E (TTM)0.00

Forward P/E0.00

Dividend Yield0.00%

Beta0.30

50-Day Avg1,266.00

200-Day Avg2,167.65

About

WSI Co., Ltd. engages in the distribution of medicines and medical devices in South Korea and internationally. The company was founded in 2016 and is headquartered in Seoul, South Korea.

Company Details

SectorFinancial Services
IndustryShell Companies
CEOMr. Yoonseok Lee
Employees26
HeadquartersWSI Building, Seoul, South Korea, 41161, Korea
Websitehttps://wsi-healthcare.com

Leadership

Mr. Yoonseok LeeChief Executive Officer · b. 1977

Financials

Income Statement

Currency: KRW	2018-12-31	2019-12-31	2020-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	-	-	26.39B	27.13B	30.88B	40.41B	51.71B
Growth (%)	-	-	-	+2.81%	+13.82%	+30.88%	+27.95%
Cost of Revenue	-	-	17.27B	17.19B	20.38B	27.56B	36.30B
Gross Profit	-	-	9.12B	9.94B	10.49B	12.85B	15.41B
Gross Margin	-	-	34.56%	36.64%	33.99%	31.81%	29.80%
Operating Expense	-	-	4.00B	6.26B	7.15B	9.00B	11.50B
Operating Income	-45.84M	-40.90M	5.12B	3.68B	3.34B	3.85B	3.92B
Operating Margin	-	-	19.40%	13.58%	10.83%	9.53%	7.57%
EBITDA	-	-	-	6.18B	5.47B	4.95B	613.10M
EBITDA Margin	-	-	-	22.79%	17.72%	12.25%	1.19%
Net Income	-25.11M	40.60M	-1.64B	4.37B	2.88B	1.32B	-3.63B
Net Income Margin	-	-	-6.22%	16.10%	9.32%	3.26%	-7.02%
R&D	-	-	-	96.76M	178.78M	653.33M	892.73M
R&D as % of Total Revenue	-	-	-	0.36%	0.58%	1.62%	1.73%
Interest Expense	0	0	0	158.06M	1.24B	2.11B	1.70B
Interest Expense % of Total Revenue	-	-	0.00%	0.58%	4.01%	5.21%	3.29%

Balance Sheet

Currency: KRW	2018-12-31	2019-12-31	2020-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	9.83B	9.93B	28.82B	57.46B	60.53B	85.40B	86.86B
Total Liabilities	1.50B	1.56B	3.93B	19.38B	20.19B	39.66B	24.20B
Total Equity	8.33B	8.37B	24.89B	37.80B	40.22B	41.43B	59.62B
Cash	1.79B	1.75B	4.74B	13.51B	6.43B	4.49B	6.97B
Total Debt	1.45B	1.50B	775.44M	-	-	-	-
Net Debt	-	-	-	-	3.71B	18.31B	3.78B

Cash Flow

Currency: KRW	2018-12-31	2019-12-31	2020-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	-44.69M	1.93B	181.87M	4.59B	2.52B	6.74B	3.09B
Investing Cash Flow	-8.00B	-740.87M	-650.19M	-	-	-	-
Financing Cash Flow	9.51B	1.47B	-213.30M	-	-	-	-
Capital Expenditure	0	65.34M	481.41M	10.38B	12.27B	223.39M	1.03B
Free Cash Flow	-	-	-	-5.79B	-9.75B	6.51B	2.06B
FCF to OCF	-	-	-	-126.20%	-387.27%	96.68%	66.65%

Earnings

Report Date	Dec 31, 2018	Mar 31, 2019	Jun 30, 2019	Sep 30, 2019	Dec 31, 2019	Mar 31, 2020	Jun 30, 2020	Sep 30, 2020	Mar 31, 2021	Jun 30, 2021	Sep 30, 2021	Dec 31, 2021	Mar 31, 2022	Jun 30, 2022	Sep 30, 2022	Dec 31, 2022	Mar 31, 2023	Jun 30, 2023	Sep 30, 2023	Dec 31, 2023	Mar 31, 2024	Jun 30, 2024	Sep 30, 2024	Dec 31, 2024	Mar 31, 2025	Jun 30, 2025	Sep 30, 2025	Dec 31, 2025	Mar 31, 2026	Jun 30, 2026
EPS Estimate	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EPS Actual	1.74	2.06	2.72	2.40	2.19	1.65	-5.74	-0.47	42.93	29.49	25.14	141.59	30.53	39.33	29.06	17.31	27.92	24.71	4.47	7.37	15.33	-6.47	-13.48	28.00	20.54	-81.54	26.24	-64.63	2.33	20.49
Surprise	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Timing	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Key Statistics & Ratios

Market Cap61.19B

Enterprise Value60.06B

Trailing P/E0.00

Forward P/E0.00

Price / Sales1.21

Price / Book0.93

Revenue (TTM)50.77B

Gross Profit (TTM)14.65B

EBITDA4.33B

Profit Margin-1.53%

Operating Margin7.95%

Return on Equity-1.97%

Return on Assets1.62%

Shares Outstanding41.51M

Shares Float22.91M

Beta0.30

Dividend Yield0.00%

Dividend Rate0.00

Payout Ratio0.00%